Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 447, 1045 (28 June 2007) | doi:10.1038/4471045a; Published online 27 June 2007
In brief
A congressional committee has unanimously approved legislation that would give the US Food and Drug Administration (FDA) significant new powers to police the safety of drugs that are already approved and on the market. The legislation passed by the House Committee on Energy and Commerce on 21 June is similar to a bill already approved last month in the Senate (see Nature 447, 247; doi:10.1038/447247a 2007
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.